Collaboration for advanced bone marrow transplant therapies in the Southeast
BMT Core: Southeast Bone Marrow Transplant Consortium
This study is looking to improve bone marrow transplant treatments for people with blood disorders and cancers, especially by including more patients from diverse backgrounds and rural areas, so you might have a chance to help with new therapies and future research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10940204 on NIH RePORTER |
What this research studies
This research focuses on enhancing access to innovative bone marrow transplant therapies through a collaboration between Emory University, the University of Alabama at Birmingham, and the University of Florida. The project aims to develop and activate phase 2 and 3 clinical trials that utilize hematopoietic stem cells and novel cell-based therapies for patients with various blood disorders and cancers. By emphasizing recruitment from underrepresented minority populations and rural areas, the consortium seeks to ensure diverse patient participation and improve treatment outcomes. Patients may have the opportunity to contribute to biospecimen collection and data for future research.
Who could benefit from this research
Good fit: Ideal candidates for participation include patients with cancers, hemoglobinopathies, or marrow failure states who are seeking advanced treatment options.
Not a fit: Patients who do not have blood disorders or cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients undergoing bone marrow transplants.
How similar studies have performed: Previous collaborations in similar research areas have shown success in improving treatment accessibility and outcomes for patients with blood disorders.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Waller, Edmund K — Emory University
- Study coordinator: Waller, Edmund K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.